Sfoglia per Autore
Prognostic significance of multifocality in primary breast cancer
1994 Morabito, A; Perrone, F; Lauria, R; Carlomagno, C; Marinelli, Alessandra; DE LAURENTIIS, M; Martignetti, A; Pettinato, G; Panico, L; Petrella, G; Gallo, Ciro; Bianco, Ar
La richiesta del consenso nella ricerca clinica: uno studio randomizzato in soggetti sani
1995 Perrone, F; DE PLACIDO, S; Giusti, C; Gallo, Ciro
Gli aspetti etici della sperimentazione nell'uomo
1995 Gallo, Ciro; Vineis, P; Catalano, G; Lojacono, G; Satolli, R.
La richiesta del consenso nelle sperimentazioni cliniche controllate
1995 Gallo, Ciro; Perrone, F.
The first breast cancer screening program in southern Italy: preliminary results from three municipalities of the Naples province
1995 DE PLACIDO, S; Nuzzo, F; Perrone, F; Carlomagno, C; Noviello, A; Delrio, P; DI PALMA, E; Pini, Mt; Cerato, Pl; Bianco, C; Rivellini, M; Petrella, G; Gallo, Ciro; Sodano, A; Bianco, Ar
Informed versus randomised consent to clinical trials
1995 Gallo, Ciro; Perrone, F; DE PLACIDO, S; Giusti, C.
CMF vs alternating CMF/EV in the adjuvant treatment of operable breast cancer. A single centre randomised clinical trial (Naples GUN-3 study)
1995 DE PLACIDO, S; Perrone, F; Carlomagno, C; Morabito, A; Pagliarulo, C; Lauria, R; Marinelli, Alessandra; DE LAURENTIIS, M; Varriale, E; Petrella, G; Gallo, Ciro; Bianco, Ar
Prognostic significance of necrosis, elastosis, fibrosis and inflammatory cell reaction in operable breast cancer
1995 Carlomagno, C; Perrone, F; Lauria, R; DE LAURENTIIS, M; Gallo, Ciro; Morabito, A; Pettinato, G; Panico, L; Bellelli, T; Apicella, A; Petrella, G; Bianco, Ar
Adjuvant chemoendocrine therapy for early breast cancer: is it worthwhile?
1995 Perrone, F; DE PLACIDO, S; Gallo, Ciro; Carlomagno, C; Lauria, R; Bianco, Ar
The prognostic value of lymphatic and blood vessel invasion in operable breast cancer
1995 Lauria, R; Perrone, F; Carlomagno, C; DE LAURENTIIS, M; Morabito, A; Gallo, Ciro; Varriale, E; Pettinato, G; Panico, L; Petrella, G; Bianco, Ar; DE PLACIDO, S.
Phase II study of intensive CEV (Carboplatin, Epirubicin and VP-16)plus G-CSF (Granulocyte-colony stimulating factor) in extensive small cell lung cancer
1995 Gridelli, C; Perrone, F; D'Aprile, M; Rossi, A; Palmeri, S; Curcio, C; Veltri, E; Ianniello, G; Lorusso, V; Palmieri, G; Rinaldi, L; Gallo, Ciro
Mitimycyn C plus vindesine plus etposide (MEV) versus mitomycin C plus vindesine plus cisplatin (MVP)in stage IV non-small-cell lung cancer: a phase III multicentre randomised trial
1996 Gridelli, C; Perrone, F; Palmeri, S; D'Aprile, M; Cognetti, F; Rossi, A; Gebbia, V; Pepe, R; Veltri, E; Airoma, G; Russo, A; Russo, A; Incoronato, P; Scinto, Af; Palazzolo, G; Natali, M; Leonardi, V; Gallo, Ciro; DE PLACIDO, S; Bianco, Ar
Selecting high-risk early breast cancer patients: what to add to the number of metastatic nodes?
1996 Perrone, F; Carlomagno, C; Lauriar, ; DE LAURENTIIS, M; Morabito, A; Panico, L; Pettinato, G; Petrella, G; Gallo, Ciro; Bianco, Ar; DE PLACIDO, S.
A predictive index of axillary nodal involvement in operable breast cancer
1996 DE LAURENTIIS, M; Gallo, Ciro; DE PLACIDO, S; Perrone, F; Pettinato, G; Petrella, G; Carlomagno, C; Panico, L; Delrio, P; Bianco, Ar
c-erbB2 overexpression decreases the benefit of adjuvant tamoxifen in early-stage breast cancer without axillary limphnode metastases
1996 Carlomagno, C; Perrone, F; Gallo, Ciro; DE LAURENTIIS, M; Lauria, R; Morabito, A; Pettinato, G; Panico, L; D'Antonio, A; Bianco, Ar; DE PLACIDO, S.
Prevalence of tuberculous infection among students in Naples
1997 Maselli, R; Signoriello, Giuseppe; DE ANGELIS, Cp; Brancato, I; Saturnino, A; Gallo, Ciro
Phase I study of carboplatin, cisplatin and cyclophosphamide without and with lenogastrim for the treatment of ovarian cancer
1997 Pignata, S; Lauria, R; Perrone, F; Ferrari, E; Biondi, E; Maffeo, A; Morabito, A; Graziano, R; Carlomagno, C; DE PLACIDO, G; Gallo, Ciro; Bianco, Ar; Pergola, M; DE PLACIDO, S.
Vinorelbine is well tolerated and active in the treatment of elderly patients with advanced non-small cell lung cancer. A two-stage phase II study
1997 Gridelli, C; Perrone, F; Gallo, Ciro; DE MARINIS, F; Ianniello, G; Cigolari, S; Cariello, S; DI COSTANZO, F; D'Aprile, M; Rossi, A; Migliorino, R; Bartolucci, R; Bianco, Ar; Pergola, M; Monfardini, S.
Il rapporto medico-paziente nella pratica e nella ricerca clinica: cosa ne pensano gli studenti di medicina?
1997 Perrone, F; Gallo, Ciro
La ricerca clinica in oncologia: il disegno degli studi
1998 Gallo, Ciro
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Prognostic significance of multifocality in primary breast cancer | 1-gen-1994 | Morabito, A; Perrone, F; Lauria, R; Carlomagno, C; Marinelli, Alessandra; DE LAURENTIIS, M; Martignetti, A; Pettinato, G; Panico, L; Petrella, G; Gallo, Ciro; Bianco, Ar | |
La richiesta del consenso nella ricerca clinica: uno studio randomizzato in soggetti sani | 1-gen-1995 | Perrone, F; DE PLACIDO, S; Giusti, C; Gallo, Ciro | |
Gli aspetti etici della sperimentazione nell'uomo | 1-gen-1995 | Gallo, Ciro; Vineis, P; Catalano, G; Lojacono, G; Satolli, R. | |
La richiesta del consenso nelle sperimentazioni cliniche controllate | 1-gen-1995 | Gallo, Ciro; Perrone, F. | |
The first breast cancer screening program in southern Italy: preliminary results from three municipalities of the Naples province | 1-gen-1995 | DE PLACIDO, S; Nuzzo, F; Perrone, F; Carlomagno, C; Noviello, A; Delrio, P; DI PALMA, E; Pini, Mt; Cerato, Pl; Bianco, C; Rivellini, M; Petrella, G; Gallo, Ciro; Sodano, A; Bianco, Ar | |
Informed versus randomised consent to clinical trials | 1-gen-1995 | Gallo, Ciro; Perrone, F; DE PLACIDO, S; Giusti, C. | |
CMF vs alternating CMF/EV in the adjuvant treatment of operable breast cancer. A single centre randomised clinical trial (Naples GUN-3 study) | 1-gen-1995 | DE PLACIDO, S; Perrone, F; Carlomagno, C; Morabito, A; Pagliarulo, C; Lauria, R; Marinelli, Alessandra; DE LAURENTIIS, M; Varriale, E; Petrella, G; Gallo, Ciro; Bianco, Ar | |
Prognostic significance of necrosis, elastosis, fibrosis and inflammatory cell reaction in operable breast cancer | 1-gen-1995 | Carlomagno, C; Perrone, F; Lauria, R; DE LAURENTIIS, M; Gallo, Ciro; Morabito, A; Pettinato, G; Panico, L; Bellelli, T; Apicella, A; Petrella, G; Bianco, Ar | |
Adjuvant chemoendocrine therapy for early breast cancer: is it worthwhile? | 1-gen-1995 | Perrone, F; DE PLACIDO, S; Gallo, Ciro; Carlomagno, C; Lauria, R; Bianco, Ar | |
The prognostic value of lymphatic and blood vessel invasion in operable breast cancer | 1-gen-1995 | Lauria, R; Perrone, F; Carlomagno, C; DE LAURENTIIS, M; Morabito, A; Gallo, Ciro; Varriale, E; Pettinato, G; Panico, L; Petrella, G; Bianco, Ar; DE PLACIDO, S. | |
Phase II study of intensive CEV (Carboplatin, Epirubicin and VP-16)plus G-CSF (Granulocyte-colony stimulating factor) in extensive small cell lung cancer | 1-gen-1995 | Gridelli, C; Perrone, F; D'Aprile, M; Rossi, A; Palmeri, S; Curcio, C; Veltri, E; Ianniello, G; Lorusso, V; Palmieri, G; Rinaldi, L; Gallo, Ciro | |
Mitimycyn C plus vindesine plus etposide (MEV) versus mitomycin C plus vindesine plus cisplatin (MVP)in stage IV non-small-cell lung cancer: a phase III multicentre randomised trial | 1-gen-1996 | Gridelli, C; Perrone, F; Palmeri, S; D'Aprile, M; Cognetti, F; Rossi, A; Gebbia, V; Pepe, R; Veltri, E; Airoma, G; Russo, A; Russo, A; Incoronato, P; Scinto, Af; Palazzolo, G; Natali, M; Leonardi, V; Gallo, Ciro; DE PLACIDO, S; Bianco, Ar | |
Selecting high-risk early breast cancer patients: what to add to the number of metastatic nodes? | 1-gen-1996 | Perrone, F; Carlomagno, C; Lauriar, ; DE LAURENTIIS, M; Morabito, A; Panico, L; Pettinato, G; Petrella, G; Gallo, Ciro; Bianco, Ar; DE PLACIDO, S. | |
A predictive index of axillary nodal involvement in operable breast cancer | 1-gen-1996 | DE LAURENTIIS, M; Gallo, Ciro; DE PLACIDO, S; Perrone, F; Pettinato, G; Petrella, G; Carlomagno, C; Panico, L; Delrio, P; Bianco, Ar | |
c-erbB2 overexpression decreases the benefit of adjuvant tamoxifen in early-stage breast cancer without axillary limphnode metastases | 1-gen-1996 | Carlomagno, C; Perrone, F; Gallo, Ciro; DE LAURENTIIS, M; Lauria, R; Morabito, A; Pettinato, G; Panico, L; D'Antonio, A; Bianco, Ar; DE PLACIDO, S. | |
Prevalence of tuberculous infection among students in Naples | 1-gen-1997 | Maselli, R; Signoriello, Giuseppe; DE ANGELIS, Cp; Brancato, I; Saturnino, A; Gallo, Ciro | |
Phase I study of carboplatin, cisplatin and cyclophosphamide without and with lenogastrim for the treatment of ovarian cancer | 1-gen-1997 | Pignata, S; Lauria, R; Perrone, F; Ferrari, E; Biondi, E; Maffeo, A; Morabito, A; Graziano, R; Carlomagno, C; DE PLACIDO, G; Gallo, Ciro; Bianco, Ar; Pergola, M; DE PLACIDO, S. | |
Vinorelbine is well tolerated and active in the treatment of elderly patients with advanced non-small cell lung cancer. A two-stage phase II study | 1-gen-1997 | Gridelli, C; Perrone, F; Gallo, Ciro; DE MARINIS, F; Ianniello, G; Cigolari, S; Cariello, S; DI COSTANZO, F; D'Aprile, M; Rossi, A; Migliorino, R; Bartolucci, R; Bianco, Ar; Pergola, M; Monfardini, S. | |
Il rapporto medico-paziente nella pratica e nella ricerca clinica: cosa ne pensano gli studenti di medicina? | 1-gen-1997 | Perrone, F; Gallo, Ciro | |
La ricerca clinica in oncologia: il disegno degli studi | 1-gen-1998 | Gallo, Ciro |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile